| 0.1209 -0.012 (-9.17%) | 07-24 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 0.19 |
1-year : | 0.22 |
| Resists | First : | 0.16 |
Second : | 0.19 |
| Pivot price | 0.14 |
|||
| Supports | First : | 0.11 |
Second : | 0.09 |
| MAs | MA(5) : | 0.13 |
MA(20) : | 0.14 |
| MA(100) : | 0.33 |
MA(250) : | 1.15 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 11 |
D(3) : | 12.3 |
| RSI | RSI(14): 28.9 |
|||
| 52-week | High : | 3.13 | Low : | 0.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IMCC ] has closed below the lower bollinger band by 11.5%. Bollinger Bands are 80.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.13 - 0.13 | 0.13 - 0.13 |
| Low: | 0.11 - 0.11 | 0.11 - 0.11 |
| Close: | 0.11 - 0.12 | 0.12 - 0.12 |
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Fri, 24 Jul 2026
Enterprise value to revenue forward of IM Cannabis Corp. – NASDAQ:IMCC - TradingView
Wed, 01 Jul 2026
Press Release: IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing - Moomoo
Wed, 01 Jul 2026
IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing - Yahoo Finance
Thu, 18 Jun 2026
IM Cannabis Corp. (Nasdaq: IMCC) moves to sell European assets, shift focus to Israel - Stock Titan
Wed, 17 Jun 2026
IM Cannabis Corp. SEC Filing (Jun 17, 2026) | IMCC EFFECT - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 9 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 35.1 (%) |
| Held by Institutions | 0.4 (%) |
| Shares Short | 373 (K) |
| Shares Short P.Month | 103 (K) |
| EPS | -2.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.57 |
| Profit Margin | -27.3 % |
| Operating Margin | -19.4 % |
| Return on Assets (ttm) | -14.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -30.7 % |
| Gross Profit (p.s.) | 0.84 |
| Sales Per Share | 5.64 |
| EBITDA (p.s.) | -0.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -0.06 |
| PEG Ratio | 0 |
| Price to Book value | -0.21 |
| Price to Sales | 0.02 |
| Price to Cash Flow | 15.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |